FMSCIK 1333141

Fresenius Medical Care AG

EDGAR filings

Customers

None disclosed

Suppliers

1 active

Top supplier share

30%

of AKBA revenue · FY to 2025-12-31

Top supplier by $

$70.9M

AKBA · FY to 2025-12-31

Latest period

Dec 31, 2025

10-K filed 2026-02-26

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available). Thin bands are named without a figure. Click a band to open its filing.

Suppliers 1

Companies that disclose FMS as a major customer, as a share of their own revenue. 1 active, 0 lapsed.

Company	% of their revenue	Est. $ from FMS	Period	Trend	Status	Source
AKBA Akebia Therapeutics, Inc.	30%	$70.9M	FY 2025-12-31	−18.0pp	Active	10-K 2026-02-26
Fresenius Medical Care Rx 30 % 48 % 40 % 10-K filed 2026-02-26 Period FY 2025-01-01 to 2025-12-31 (30%), FY 2024-01-01 to 2024-12-31 (48%), FY 2023-01-01 to 2023-12-31 (40%)Accession 0001517022-26-000020

Alerts are coming

Get an email when FMS's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.